Tender detail
Supply of dienogest and ethinylestradiol medicines and drospirenone and ethinylestradiol medicines
Summary
SPMS is procuring medicines for Portugal’s public health institutions under the 2027 National Reproductive Health Programme. Lot 1 covers 35,295 units of dienogest 2 mg and ethinylestradiol 0.03 mg (3/6 cycles); lot 2 covers 900 units of drospirenone 3 mg and ethinylestradiol 0.02 mg (1/3 cycles, 24+4 regimen). The total estimated value is €85,350 excluding VAT, and the contract runs for up to 12 months.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.